Charles River Laboratories International Statistics
NYSE: CRLHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 298.00 0.00%
Charles River Laboratories International by the numbers
Charles River Laboratories International has a market capitalization of $14.35 billion based on 48.17M shares outstanding. With trailing EPS of $-4.80, Charles River Laboratories International is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.2% above its 50-day average and 40.8% above its 200-day average.
Average daily trading volume is 947.94K shares, or about $282.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CRL valuation vs. peer median
| Metric | CRL | Peer median | Difference |
|---|---|---|---|
| Market cap | $14.35B | $1.11B | +1198% |
| Forward P/E | 23.3 | 16.7 | +40% |
| Avg. volume | 947.94K | 750.04K | +26% |
Peer median across 8 companies: ICLR, MEDP, INCY, ABSI, OABI, NRC, MXCT, ONMD.
Valuation
- Market cap
- $14.35B
- Forward P/E
- 23.33
- Price / sales (latest FY)
- 3.57
- EPS (TTM)
- $-4.80
- Shares outstanding
- 48.17M
Price and trading
- Previous close
- 300.30
- Open
- 297.01
- Day range
- 288.43 – 298.21
- 52-week range
- 146.20 – 333.30
- 52-week change
- +76.54%
- 50-day moving average
- 280.56
- 200-day moving average
- 211.63
- Beta
- —
- Volume
- 1.18M
- Average volume
- 947.94K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 14.35B
- Forward Pe
- 23.33
- Eps
- -4.80
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 333.30
- Week52 Low
- 146.20
- Avg Volume
- 947.94K
- Shares Outstanding
- 48.17M
- Ma50
- 280.56
- Ma200
- 211.63
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -10.59%
- Pct From52w Low
- 103.83%